No Form FDA 483 Observations in First U.S. FDA Inspection of ChemExpress’ Ma’anshan Site
A Significant Milestone in Global Quality Compliance, Strengthening API and HPAPI CDMO Services for Global Pharmaceutical Innovation SHANGHAI, SHANGHAI, CHINA, November 2, 2026 /EINPresswire.com/ -- ChemExpress (Shanghai Haoyuan Chemexpress Co., Ltd.) …